Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06454422
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Study Overview
Official Title:
Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension to Enhance Exercise Tolerance Reduce Negative Emotions and Quality of Life A Randomized Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PAH
Brief Summary:
Aims and objective The primary objective of this study was to assess the effects of a traditional Chinese Qigong practice known as Wuqinxi on activity tolerancenegative emotions and quality of life in pulmonary arterial hypertension patients
Methods In the current prospective randomized-controlled clinical trial 60 patients with pulmonary arterial hypertension were randomly assigned to one of two groups intervention or control Participants in the intervention group received targeted pharmacological therapy and five sessions of qigong exercise per week In contrast individuals in the control group underwent targeted drug therapy and routine care Observe the change in exercise tolerance as measured by the 6-minute walking distance 6MWD Serological indicators n-terminal brain natriuretic peptide precursor NT-pro BNP negative emotionsPHQ-9GAD-7and the MOS Item Short Form Health Survey SF-36 or emPHasis-10 were used to assess patients condition and quality of life
Methods In the current prospective randomized-controlled clinical trial 60 patients with pulmonary arterial hypertension were randomly assigned to one of two groups intervention or control Participants in the intervention group received targeted pharmacological therapy and five sessions of qigong exercise per week In contrast individuals in the control group underwent targeted drug therapy and routine care Observe the change in exercise tolerance as measured by the 6-minute walking distance 6MWD Serological indicators n-terminal brain natriuretic peptide precursor NT-pro BNP negative emotionsPHQ-9GAD-7and the MOS Item Short Form Health Survey SF-36 or emPHasis-10 were used to assess patients condition and quality of life
Detailed Description:
In the previous study we examined the effects of comprehensive respiratory function exercise on exercise tolerance in patients with PAH The results indicated that limb exercise combined with breath regulating guidance affects patients physical healthGiven these TCM principles the current study investigated the clinical utility of Wuqinxi for improving patients exercise tolerance and quality of life by comparing the intervention and control groups NT-pro BNP scores 6MWD data negative emotionsand quality of life indices
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None